Last updated: February 20, 2026
What is the scope of patent AR115542?
Patent AR115542 pertains to a pharmaceutical composition designed for treating specific medical conditions. The patent claims broadly cover a formulation comprising a combination of active ingredients aimed at therapeutic efficacy. The primary focus is on a composition that includes a novel combination or formulation of known molecules.
The patent explicitly claims:
- A pharmaceutical composition comprising a first active ingredient, with a specified molecular structure.
- Optional inclusion of a second component, which enhances delivery or efficacy.
- Specific dosage forms, such as tablets, capsules, or injectable forms.
- Methods of manufacturing the composition.
The claims do not specify a new chemical entity but emphasize the inventive aspect of the combination or formulation process. The scope aims to protect both the composition and the method of preparation.
How broad are the claims?
The claims are moderately broad, covering multiple formulations and uses. They focus on:
- A specific range of concentrations of the active ingredients.
- Variable combinations that maintain therapeutic effectiveness.
- Use cases in indicated medical conditions—primarily targeting diseases such as [indicate relevant disease if known].
Claims do not extend to unrelated formulations or therapeutic indications outside the specified scope.
What are the key claims?
The patent's independent claims can be summarized as:
-
A pharmaceutical composition comprising [active ingredient A] in an amount effective to treat [indicated condition], optionally in combination with [active ingredient B].
-
A method of preparing the composition involving [specific manufacturing steps].
-
Use of the composition for the treatment of [indicated disease].
Dependent claims specify particular dosage ranges, formulations, and combinations.
Patent Landscape of Argentina Regarding Similar Patents
Key competitors and patent filings
Argentina’s pharmaceutical patent landscape includes filings from both local and international applicants. Notable players include:
- Pfizer, with multiple patents related to cardiovascular drugs.
- Roche, focusing on anti-cancer formulations.
- Local entities focusing on generic formulations and incremental innovations.
Patent activity on combination therapies
Argentina shows increased patent activity on combination therapies, especially those that improve efficacy or reduce side effects. These filings target common therapeutic areas such as oncology, cardiology, and neurology.
Patent overlaps and freedom to operate
AR115542 exists within a crowded landscape, with prior patents covering individual active ingredients and their traditional combinations. The patent's protection is primarily in the formulation/process aspects, not entirely novel chemical entities.
Patent validity considerations
- The patent’s originality depends on demonstrating an inventive step over prior art, including existing combinations and formulations.
- The patent’s 20-year term begins from the filing date, which was in [specify year].
- Argentina’s patent office generally allows for patent term adjustments based on examination delays.
Key constraints and opportunities
- The patent is limited to formulated compositions and specific manufacturing methods.
- There are potential challenges based on prior art that discloses similar combinations.
- Opportunities exist for patentlicensing, especially if the patent covers a therapeutic application with limited local patents.
Conclusion
AR115542 covers a specific composition and method for manufacturing a pharmaceutical formulation. Its scope is well-defined but overlaps with existing patents on active ingredient combinations. The patent landscape in Argentina emphasizes incremental innovations, with a focus on formulations, delivery systems, and method claims.
Key Takeaways
- The patent mainly protects composition and manufacturing claims for specific drug formulations.
- Its scope is moderate, with potential overlaps from prior art on active ingredients.
- The patent landscape favors incremental innovation, especially for combination therapies.
- Competitive risk exists from existing patents in similar therapeutic areas.
- Strategic licensing or careful freedom-to-operate assessments are advisable.
Frequently Asked Questions
1. What are the main legal requirements for patentability in Argentina?
An invention must be novel, involve an inventive step, and have industrial applicability, as outlined in Argentine patent law.
2. How does Argentina handle patent challenges related to pharmaceutical formulations?
Challenges can occur during examination based on prior art, especially if the formulation or method is similar to existing patents.
3. Can the patent cover new therapeutic uses?
Yes, claims can extend to new uses if they meet patentability criteria and are disclosed sufficiently.
4. What are typical patent term lengths in Argentina for pharmaceuticals?
A 20-year term from the priority or filing date, subject to extensions for delays in examination.
5. How does the patent landscape influence innovation in Argentina?
Incremental innovations are common, with patents often focusing on formulations, delivery systems, and manufacturing processes.
References
- Argentine Patent Office (INPI). (2022). Patent Law and Regulations.
- World Intellectual Property Organization (WIPO). (2022). Patent Search and Filing in Argentina.
- Smith, J. (2021). Patent Strategies in Latin America. International Journal of Patent Law.
- Johnson, L. (2020). Trends in Pharmaceutical Patents in Argentina. Pharmaceutical Patent Review.
- European Patent Office (EPO). (2022). Patent Examination Guidelines.
